Product Recalls: October 13, 2021 – November 17, 2021
Health Letter, December 2021
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS II
Cefixime capsules, 400 mg, 50-count bottles. Manufactured by: Alken Laboratories Ltd. Lot #: 20140282, exp. date: Dec 2021.
Dr. Reddy’s ezetimibe and simvastatin tablets; 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg or 10 mg/80 mg; 30-, 90-, 500- and 1,000-count bottles. Manufactured by: Dr. Reddy’s Laboratories LA LLC. Lot #: L100256, exp. date: 01/2023; Lot #: L100257, exp. date: 01/2023; Lot #: L100298 and L100304, exp. date: 01/2023; Lot #: L100235, exp. date: 01/2023; Lot #: L100160, exp. date: 01/2023; Lot #: L100249, exp. date: 01/2023; Lot #: L100250, exp. date: 01/2023; Lot #: L100158, exp. date: 12/2022; Lot #: L100159, exp. date: 12/2022; Lot #: L100208, exp. date: 01/2023; Lot #: GS038610, exp. date: 01/2023; Lot #:GS038891, exp. date: 1/2023; Lot #: GS040048, exp. date: 1/2023.
Glipizide extended-release tablets, 2.5 mg, 30 tablets (3 blister cards each with 10 individually blistered doses). Manufactured by: Patheon Pharmaceuticals Inc. Lot #: 194141, exp. date: 03/31/2022.
Imipramine pamoate capsules, 125 mg, 30-count bottle. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Lot #: H002205, exp. date: 08/2023.
Irbesartan tablets; 75, 150 or 300 mg; 30- and 90-count bottles. Lot #: H000843, exp. date: 28/02/2023; Lot #: H805727, exp. date: 30/11/2021; Lot #: H901579, exp. date: 31/03/2022; Lot #: H000844, exp. date: 28/02/2023; Lot #: H000964, exp. date: 31/03/2023; Lot #: H804311, exp. date: 31/08/2021; Lot #: H805267, exp. date: 30/11/2021; Lot #: H805268, exp. date: 30/11/2021; Lot #: H805269, exp. date: 30/11/2021; Lot #: H805725, exp. date: 30/11/2021; Lot #: H805726, exp. date: 30/11/2021; Lot #: H901497, exp. date: 31/01/2022; Lot #: H901577, exp. date: 31/03/2022; Lot #: H901578, exp. date: 31/03/2022; Lot #: H902258, exp. date: 31/05/2022; Lot # H804403, exp. date: 31/08/2021; Lot #: H805251, exp. date: 30/11/2021; Lot #: H805640, exp. date: 30/11/2021; Lot #: H901580; exp. date: 30/04/2022; Lot #: H804492, exp. date: 31/08/2021; Lot #: H805252, exp. date: 30/11/2021; Lot #: H805253, exp. date: 30/11/2021; Lot #: H805641, exp. date: 30/11/2021; Lot #: H805642, exp. date: 30/11/2021; Lot #: H805643, exp. date: 30/11/2021; Lot #: H901581, exp. date: 30/04/2021; Lot #: H902139, exp. date: 30/04/2022; Lot #: H902140, exp. date: 30/04/2022; Lot #: H804310, exp. date: 31/08/2021; Lot #: H900050, exp. date: 30/11/2021; Lot #: H902262, exp. date: 31/05/2022; Lot # H000845, exp. date: 28/02/2023; Lot #: H000846, exp. date: 28/02/2023; Lot #: H000965, exp. date: 31/03/2023; Lot #: H805345, exp. date: 30/11/2021; Lot #: H805346, exp. date: 30/11/2021; Lot #: H805347, exp. date: 30/11/2021; Lot #: H805724, exp. date: 30/11/2021; Lot #: H900061, exp. date: 31/12/2021; Lot #: H900062, exp. date: 31/12/2021; Lot #: H900445, exp. date: 31/01/2022; Lot #: H901489, exp. date: 31/03/2022; Lot #: H901490, exp. date: 31/03/2022; Lot #: H901491, exp. date: 31/03/2022; Lot #: H902261, exp. date: 31/05/2022.
Irbesartan and hydrochlorothiazide tablets, 150/12.5 mg or 300 mg/12.5 mg, 30- and 90-count bottles. Lot #: H804537, exp. date: 30/09/2021; Lot #: H805148, exp. date: 31/10/2021; Lot #: H900063, exp. date: 31/10/2021; Lot #: H900522, exp. date: 31/12/2021; Lot #: H901582, exp. date: 31/01/2022; Lot #: H000963, exp. date: 30/04/2022; Lot #: H804507, exp. date: 30/04/2022; Lot #: H804536, exp. date: 30/09/2021; Lot #: H805070, exp. date: 31/10/2021; Lot #: H805149, exp. date: 31/10/2021; Lot #: H900064, exp. date: 31/12/2021; Lot #: H900523, exp. date: 31/01/2022; Lot #: H901583, exp. date: 30/04/2022; Lot #: H902530, exp. date: 30/04/2022; Lot #: H804192, exp. date: 31/08/2021; Lot #: H805348, exp. date: 30/11/2021; Lot #: H900065, exp. date: 31/12/2021; Lot #: H902264; exp. date: 31/05/2022; Lot #: H804082, exp. date: 31/08/2021; Lot #: H804121, exp. date: 31/08/2021; Lot #: H804338, exp. date: 31/08/2021; Lot #: H804538, exp. date: 30/09/2021; Lot #: H804539, exp. date: 30/09/2021; Lot #: H805349, exp. date: 30/11/2021; Lot #: H805350, exp. date: 30/11/2021; Lot #: H900066, exp. date: 31/12/2021; Lot #: H900067, exp. date: 31/12/2021; Lot #: H902265, exp. date: 31/05/2022; Lot #: H902275, exp. date: 31/05/2022; Lot #: H902276, exp. date: 31/05/2022; Lot #: H902531, exp. date: 30/04/2022; Lot #: H902532, exp. date: 30/04/2022.
Methocarbamol tablets; 500 mg; packaged in 30-, 60- and 90-count bottles. Prinston Laboratories. Lot #: 163935, exp. date: 10/31/2022.
Omeprazole delayed-release capsules, 20 mg (equivalent to 20.6 mg omeprazole magnesium), 24-hour, 14-count capsules per bottle within a carton. Distributed by Cardinal Health. Lot #: BT001594C.
Potassium chloride extended-release tablets, 10 mEq (750 mg), 500 Tablets. Manufactured by: Strides Shasun Limited. Lot #: 7240840A, exp. date: 12/31/2021.
Tadalafil tablets, 5 or 20 mg, 30-count bottles. Manufactured for: Northstar Rx LLC. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: DNC1127A, exp. date: 05/2023; Lot #: DNC0814A or DNC0815A, exp. date: 04/2023.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.